Navigation Links
Blue Sky BioServices Expands its Executive Team - Announces Appointment of Ted Marple as President and CEO
Date:7/7/2013

WORCESTER, Mass., July 5, 2013 /PRNewswire-iReach/ -- Blue Sky BioServices is pleased to announce that Edward (Ted) Marple has been appointed as President and CEO of Blue Sky BioServices.  Mr. Marple brings significant business and operational experience that will enable Blue Sky's continued growth and leadership as a key partner to pharmaceutical and biotechnology companies' research and development teams.

Mr. Marple was most recently Chief Business Officer at Xcellerex, a bioprocess company offering bioprocess equipment and GMP biomanufacturing services to pharmaceutical and biotech companies, prior to its acquisition by GE Healthcare in May 2012.  At Xcellerex he was responsible for focusing and executing on the business strategy of the company.  He previously led the finance and commercial operations at Xcellerex. 

"Adding Ted provides the team with a smart, energetic leader and catalyst for future scalability of customers and services," said Paul Wengender, Blue Sky's founder.  "His recent leadership roles in finance, operations and strategy will be key additions to help us expand.  We are excited to have him onboard as we continue to build Blue Sky as the leader in providing 'Gene Through Screen' contract research organization (CRO) services."

With Mr. Marple's appointment, Mr. Wengender will focus his efforts on the commercial efforts of Blue Sky, and has assumed the role of Chief Commercial Officer.  Moving forward he will be responsible for sales and marketing, continuing to expand the customer relationships and forming new partnerships with customers globally.  Mr. Wengender will remain a member of the company's Board of Directors.  Norm Garceau, who provides the scientific leadership for the company, will continue to lead the business's laboratory operations as Chief Scientific Officer.

"I am joining a great team of thought leaders," said Mr. Marple.  "Paul has established and grown a company with proven leadership in quality, innovation and execution for its customers.  I look forward to working with Paul and Norm and our customers to build on the solid foundation at Blue Sky as we ensure the company executes on its strategic objectives and continues to grow."

"The Board is delighted to have Ted join Blue Sky," added Peter Glick, Chairman of the Board of Directors.  "Ted brings a critical managerial skill set and industry experience that complement Paul and Norm, and we believe we have a great team to take the company forward as it grows."

About Blue Sky BioServices

Blue Sky BioServices is the leading contract research organization (CRO) providing Gene Through Screen services in the pharmaceutical and biotechnology R&D market.  Our clients enhance the quality and speed of their research by utilizing Blue Sky's premium services such as vector gene synthesis, E. coli, Insect and Mammalian Scale-Up, antibody cloning and production, protein purification, radiometric assays, and assay execution (screening).  Blue Sky invests heavily in experienced people, leading-edge technology, and state-of-the-art laboratory facilities.  Because of these investments in people and quality systems, Blue Sky provides unmatched quality and turnaround times.  Blue Sky is majority owned by Ampersand Capital Partners, a healthcare-focused, middle market private equity firm.  For more information, please visit www.blueskybioservices.com.

About Ampersand Capital Partners

Ampersand is a Boston-based private equity firm with a focus on middle market growth equity investments in the Healthcare sector.  Ampersand leverages its unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams.  Ampersand's portfolio has included more than 20 years of successful investments in healthcare.  For more information, please visit www.ampersandcapital.com.


 

Media Contact: Megan Kelly, Blue Sky BioServices, (508) 749-3226 x314, megan.kelly@blueskybiotech.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 


'/>"/>
SOURCE Blue Sky BioServices
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Paragon Bioservices, Inc. Wins The 2012 CMO Leadership Award
2. MicroConstants Expands Biomarker Testing and Analysis Services for Preclinical and Clinical Diagnostic Research
3. Grunenthal Expands Use of BioClinicas Next Generation Trident IWR/IVR for Global Trial
4. Amerivet Solutions Expands to Manufacture Complex Metal Designs
5. Life Technologies Expands Range of Stem Cell Reprogramming Solutions
6. QIAGEN Significantly Expands its Offering of Assay Panels for Next-generation Sequencing (NGS) Complemented by Ingenuity Analysis and Interpretation Capabilities
7. Senior Home Care Expands Home Health Telemonitoring into Spring Hill, Fla.
8. Novira Therapeutics Expands Management Team with Appointment of Klaus Klumpp, Ph.D., the Former Global Head of Roches Virology Discovery Initiatives, as Vice President Discovery Research
9. Sotera Wireless Expands Board Of Directors
10. NextDocs Expands Customer Roster by More Than 10 Percent
11. Edison Expands North American Healthcare Sector Coverage With Initiation of Coverage on Bellus Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... -- Global Health Intelligence (GHI), the leading healthcare ... published its 2017 ranking of the Best-Equipped Hospitals in ... analysis from GHI,s hospitals database for Latin America , ... The GHI database covers 86% of the hospitals in ... points for each institution in key areas such as beds, ...
(Date:5/9/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... it has earned a spot on Forbes, ... was ranked among 500 U.S. employers as well as ... and Services. The annual Forbes ... survey of over 30,000 employees across 25 industries. The ...
(Date:5/8/2017)... NEW YORK , May 8, 2017 ... in the transition from fee for service reimbursement. Black ... April 2017. 1.       The Market for ... 77% of physician practices with 3 or ... Compliance Technology Solutions by Q4. "Given the magnitude of ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... 26, 2017 , ... Amir Qureshi, MD is the first physician in Arkansas ... stimulation system. The Nuvectra™ Algovita SCS System has been FDA approved as a treatment ... in Arkansas to introduce the most powerful SCS system and the only stretchable lead ...
(Date:5/26/2017)... MA (PRWEB) , ... May 26, 2017 , ... On ... Act (AHCA), which narrowly passed the U.S. House on May 4, would result in ... be expected under continued implementation of the 2010 Patient Protection and Affordable Care Act ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled ... a new, informational blog post on insurance options. If a Bay Area patient has ... help save time and money. Visiting an in-network provider for a second opinion can ...
(Date:5/26/2017)... ... 2017 , ... “Cactus Jack: Against All Odds”: the story of Coach Cactus ... Against All Odds” is the creation of published author, Walter Hubbard, a retired wildlife ... Carlisle’s third child Jane. Walter. Walter and Jane have three adult children and ...
(Date:5/24/2017)... , ... May 24, 2017 , ... Altec ... participation in nVerge 2017 – a one-day technology conference in San Diego, CA. ... solution, which allows users to fully utilize and enhance their Sage ERP solutions by ...
Breaking Medicine News(10 mins):